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Introduction
Aminoacidurias are caused by defective amino acid transport across the renal epithelium. Inborn errors of amino acid transporters include lysinuric protein intolerance (LPI) (MIM #222700), cystinuria (MIM #220100), iminoglycinuria (MIM #242600), dicarboxylic amino aciduria (MIM #222730) and Hartnup disorder (MIM #234500). Next to defective amino acid transporters, transport of amino acids can also be impaired by general dysfunction of the renal tubule, as occurs for example in Fanconi syndrome [5] and Lowe syndrome [8] . Aminoacidurias are biochemically classified according to their specific amino acid excretion pattern.
Hartnup disorder has an estimated frequency of 1:20.000 [9] and is caused by a deficiency of the sodium dependent B 0 AT1 neutral amino acid transporter, encoded by SLC6A19. This transporter is mainly expressed in the brush border membrane of the proximal kidney tubules and in the jejunum [7, 12, 13] . The disorder is biochemically characterized by increased excretion of neutral amino acids including alanine, serine, threonine, valine, leucine, isoleucine, phenylalanine, tyrosine, asparagine, glutamine, tryptophan, histidine and citrulline, whereas excretion of other amino acids is reported to be less affected (Nanto-Salonen et al. 2006 , Vademecum Metabolicum). The impaired renal and intestinal transport of neutral amino acids is a risk factor for developing amino acid deficiencies, tryptophan deficiency in particular. As tryptophan is the precursor for serotonin and nicotinamide, also known as vitamin B3, the clinical symptoms of Table 1 Amino acid excretion of patients with Hartnup disorder. Amino acid excretion patterns of patients with Hartnup disorder in mmol/mmol creatinine. Age group: age adjusted reference values were obtained from literature, taking into account seven age groups: first week (1), first week till first month (2), first month till four months (3), four months till two years (4), two years till ten years (5), ten years till eighteen years (6) and above eighteen years (7) [1] . Hartnup amino acids: alanine to glutamine. Other amino acids: arginine to α-aminobutyric acid.
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Hartnup disorder are those of a nicotinamide deficiency. Reported symptoms include dermatological symptoms, particularly a pellagralike rash and light-sensitive dermatitis, intermittent cerebellar ataxia and psychiatric symptoms as emotional instability, delirium and hallucinations [3] . All symptoms respond well to treatment with vitamin B3 [15] . To date, many individuals remain asymptomatic [14] , likely because of a sufficiently high intake of protein, tryptophan, vitamin B3 or a combination thereof [3] . However, even in asymptomatic patients, accurate diagnosis of Hartnup disorder is essential [4, 14] , to ensure correct differentiation of Hartnup disorder from other aminoacidurias, which would demand alternative diagnostic trajectories. Biochemically, Hartnup disorder is diagnosed based on the amino acid excretion profile. Here, we demonstrate that patients with Hartnup disorder may present with an amino acid excretion pattern that closely resembles generalized aminoaciduria [2, 3, 6] . We show that this potential misdiagnosis can be overcome by quantification, visualization and computation of urinary amino acids, enabling us to correctly discriminate Hartnup disorder from other causes of aminoaciduria.
Methods

Patient inclusion
Twenty-seven urine samples of 11 patients with Hartnup disorder were analyzed. Four of these patients were included at the University Medical Centre Utrecht. Hartnup disorder was confirmed through PCR amplification followed by Sanger sequencing of SLC6A19. Patient 1 is compound heterozygous for the pathogenic SLC6A19 c.517G > A (p.Asp173Asn) and c.1173+2T > G (p.?) mutations [13] . Patient 2, 3 and 4 are homozygous for the common SLC6A19 c.517G > A (p.Asp173Asn) mutation. Patient 3 and 4 are siblings. To extend the Hartnup disorder cohort, amino acid excretion patterns of seven patients with Hartnup disorder previously published by Potter et al. were included [11] . Hartnup disorder was genetically confirmed in these patients by Seow et al. [13] . One patient (patient 2/II) was excluded, because of heterozygosity for cystinuria type II. In the patients from Potter et al., amino acid excretion patterns were quantified using a Beckman 6300 amino acid analyzer [11] .
To differentiate Hartnup disorder from other aminoacidurias, 10 samples of 7 patients with generalized aminoaciduria, 16 samples of 2 patients with LPI and 42 samples of 7 patients with cystinuria were included, coming to a combined aminoaciduria cohort of 68 samples of 16 patients, all from the University Medical Centre Utrecht. All diagnoses were genetically confirmed.
Quantification of amino acid excretion
Amino acid excretion was quantified at the University Medical Centre Utrecht using a Biochrom amino acid analyzer (Isogen Life Sciences, de Meern, the Netherlands) according to diagnostic standards. Amino acid excretion was expressed in mmol/mol creatinine. Age adjusted reference values were obtained from literature, taking into account seven age groups: first week (1), first week till first month (2), first month till four months (3), four months till two years (4), two years till ten years (5), ten years till eighteen years (6) and above eighteen years (7) [1].
Statistical analysis
Amino acid fold changes were calculated by dividing the quantified excretion values over the upper limit of the age-adjusted reference value. Amino acids were grouped into Hartnup amino acids (HAA) versus other amino acids (OAA). HAA included alanine, serine, threonine, valine, leucine, isoleucine, phenylalanine, tyrosine, asparagine, glutamine, tryptophan, histidine and citrulline (Nanto-Salonen et al. 2006, Vademecum Metabolicum), and OAA included arginine, lysine, aspartic acid, glutamic acid, glycine, cysteine, methionine, proline, ornithine, taurine and alpha-aminobutyric acid. Statistical analyses were performed using R programming language. Results were visualized in both heatmaps and scatter plots. Data files and R code are available upon request.
Results
Amino acid excretion patterns of the patients with Hartnup disorder in the Utrecht cohort are presented in Table 1 . This table displays that increased excretion of amino acids is not restricted to HAA, but also includes many OAA, including cystine (in all 20 samples), alpha-ami- (Fig. 1A) .
We assessed whether the degree of increase could aid differentiation of Hartnup disorder from other aminoacidurias. Indeed, quantification of amino acid excretion values and computation of amino acid fold changes enabled visual discrimination between Hartnup disorder and generalized aminoaciduria (Fig. 1B) . The heatmap demonstrating the fold changes shows that, unlike in patients with generalized aminoaciduria, in both Hartnup disorder cohorts the fold changes of HAA were strikingly higher than the fold changes of OAA. LPI and cystinuria could also be recognized easily: LPI based on clear increases of arginine, lysine and ornithine and cystinuria based on the additional increase of cystine (Fig. 1B) .
In patients with Hartnup disorder, the mean fold change of HAA ranged from 8.1 for phenylalanine to even 49.7 for valine. Histidine, an amino acid classically related to Hartnup disorder, was unexpectedly only slightly elevated, with a mean fold change of 3.1. Surprisingly, this was even lower than in generalized aminoaciduria, for which a mean fold change of 7.8 was calculated. Histidine excretion, while increased in 18/20 samples, seemed similar to the excretion of OAA (range mean fold change 0.9-13.1). Computation of the ratio of the mean fold change of HAA over OAA (including histidine) clearly distinguished Hartnup disorder from other aminoacidurias ( Table 2 , Fig. 2A ). The mean HAA/OAA ratio in the Hartnup cohort was 6.1, whereas the mean HAA/OAA ratio in the aminoaciduria cohort was only 0.2 (MannWhitney test p < .0001). Moreover, no overlap was observed between the two cohorts, as the minimum value of the HAA/OAA ratio in Hartnup disorder was 2.4, while the maximum value of the HAA/OAA ratio in other aminoacidurias was 1.6 (Table 2, Fig. 2A) .
Computation of the HAA/OAA ratio required quantification of all included amino acids ( Table 2 ). Acknowledging that this is not standard practice in many metabolic diagnostic laboratories, we also evaluated the performance of a ratio using a limited set of amino acids, specifically aiming to distinguish Hartnup disorder from generalized aminoaciduria. Only six amino acids were quantified in all samples of patients with generalized aminoaciduria: serine, alanine, glycine, histidine, cystine and lysine. Of these amino acids, the differences in fold changes between these two patients groups were the largest for alanine, glycine and histidine. The ratio of the fold change of alanine over the mean fold change of glycine and histidine clearly discriminated Hartnup disorder from generalized aminoaciduria, with a mean Ala/(Gly + His) ratio in the Hartnup cohort of 4.3, contrasting with a mean Ala/(Gly + His) ratio of only 0.7 in the generalized aminoaciduria cohort. Even for this limited ratio, there was no overlap between the two cohorts, as the minimum value in the Hartnup cohort was 2.7, while the maximum value for the ratio in generalized aminoaciduria was 1.3 ( Table 2 , Fig. 2B ).
Discussion
In this study we demonstrated that quantitative assessment of the degree of the increases, rather than qualitative assessment of increases of amino acid excretion, enhances correct discrimination of Hartnup disorder from other aminoacidurias. We introduce the HAA/OAA ratio as a new and easily applicable diagnostic tool to discriminate Hartnup disorder from other aminoacidurias. Moreover, we demonstrate that even the limited Ala/(Gly + His) ratio, requiring quantification of only three amino acids, can distinguish Hartnup disorder from generalized aminoaciduria.
Quantification of all urinary amino acid concentrations revealed that, in addition to the amino acids reported to be excreted excessively in Hartnup disorder (Nanto-Salonen et al. 2006, Vademecum Metabolicum), cystine, alpha-aminobutyric acid, glycine, lysine, citrulline, glutamic acid, aspartic acid and arginine can be increased as well in the urine of patients with Hartnup disorder [2, 3, 6] . Unexpectedly, the excretion of histidine, an amino acid of which the intestinal uptake and tubular reabsorption is expected to be affected (Nanto-Salonen et al. 2006, Vademecum Metabolicum), was increased only modestly in 18/20 samples, contrasting with the extent of the excretion of HAA. Whether the complete range of amino acids excreted by patients with Hartnup disorder can be explained by a broader substrate specificity of the B 0 AT1 transporter than currently described, or whether the aberrant transport of amino acids in the proximal tubule of patients with Hartnup disorder affects (saturation of) other amino acid transporters remains to be elucidated. It is of interest that the Hartnup disorder cohort derived from Potter et al. described a less generalized aminoaciduria in their patients, even though the same reference values were used. We speculate that differences in the patient age at time of sampling (all adults in Potter et al.) may affect the amino acid excretion pattern. Moreover, differences in nutrition, particularly a higher protein intake, could have contributed to the here observed more pronounced generalized aminoaciduria [3] . Still, despite these differences, the distribution of the calculated ratios is comparable, corroborating the accuracy of these ratios in discriminating Hartnup disorder from other aminoacidurias. However, given the relatively small sample sizes of the two cohorts, it would be of interest to assess the generalizability of the calculated ratio in another, independent cohort of patients with Hartnup disorder.
As nutritional intake, including protein intake, has been increasing in many countries over the past decades [3] , the degree to which individuals with Hartnup disorder demonstrate amino acid excretion patterns mimicking generalized aminoaciduria might increase as well, explaining why quantification of urinary amino acid concentrations was not required in the past, but is expedient now.
In conclusion, we here report that excretion values of amino acids not classically related to Hartnup disorder, are frequently elevated in patients with Hartnup disorder. This may induce a risk of misdiagnosis as generalized aminoaciduria and preclusion from vitamin B3 treatment. By changing the focus from absolute to relative increase of amino acid excretion and by calculating the HAA/OAA ratio, we introduce a diagnostic tool that enhances correct discrimination of Hartnup disorder from other aminoacidurias.
Take home message
The fold change ratio of Hartnup amino acids over other amino acids ensures correct diagnostic differentiation of Hartnup disorder from other aminoacidurias.
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